Inferior intravitreal injection site associated with a higher incidence of post-injection endophthalmitis / 国际眼科杂志(Guoji Yanke Zazhi)

?AlM:To determine whether inferior injections had a higher incidence of post-injection endophthalmitis than superior injections. The incidence of endophthalmitis is higher for inferior than superior trabeculectomy filtering blebs, possibly due to bacteria pooling in the inferior tear lake. ? METHODS: A practice - wide database of endophthalmitis cases identified 5 occurring during the two-year study period. A retrospective review of 8 672 injections in 1 121 eyes of 909 patients treated during the same two-year study period was performed in order to assess the injection site location. ?RESULTS: Five eyes developed presumed infectious endophthalmitis. Eighty percent of endophthalmitis cases were injected inferiorly, even though 84. 6% of the total cohort was injected superiorly. The odds ratio of infection associated with inferior injection location is 22. 1 (P=0. 006). ? CONCLUSlON: Endophthalmitis after intravitreal injection is rare, occurring in only 0. 025% of injections overall. Avoiding intravitreal injections in the inferior quadrants may further reduce the rate of endophthalmitis.

Frequency of 22q11 deletions in patients with conotruncal defects.

OBJECTIVES: This study was designed to determine the frequency of 22q11 deletions in a large, prospectively ascertained sample of patients with conotruncal defects and to evaluate the deletion frequency when additional cardiac findings are also considered. BACKGROUND: Chromosome 22q11 deletions are present in the majority of patients with DiGeorge, velocardiofacial and conotruncal anomaly face syndromes in which conotruncal defects are a cardinal feature. Previous studies suggest that a substantial number of patients with congenital heart disease have a 22q11 deletion. METHODS: Two hundred fifty-one patients with conotruncal defects were prospectively enrolled into the study and screened for the presence of a 22q11 deletion. RESULTS: Deletions were found in 50.0% with interrupted aortic arch (IAA), 34.5% of patients with truncus arteriosus (TA), and 15.9% with tetralogy of Fallot (TOF). Two of 6 patients with a posterior malalignment type ventricular septal defect (PMVSD) and only 1 of 20 patients with double outlet right ventricle were found to have a 22q11 deletion. None of the 45 patients with transposition of the great arteries had a deletion. The frequency of 22q11 deletions was higher in patients with anomalies of the pulmonary arteries, aortic arch or its major branches as compared to patients with a normal left aortic arch regardless of intracardiac anatomy. CONCLUSIONS: A substantial proportion of patients with IAA, TA, TOF and PMVSD have a deletion of chromosome 22q11. Deletions are more common in patients with aortic arch or vessel anomalies. These results begin to define guidelines for deletion screening of patients with conotruncal defects.

Elevated carcinoembryonic antigen in patients with androgen-independent prostate cancer.

BACKGROUND: Extraordinarily high serum carcinoembryonic antigen (CEA) values have been reported to be associated with many malignant disorders, including carcinoma with primary sites in the colon, pancreas, stomach, bile duct, lung, and breast. This study was undertaken to determine if a marked elevation of serum CEA levels in androgen-independent prostate cancer patients exists, and to evaluate the potential of using CEA monitoring as a marker for disease progression. METHODS: Records from 141 patients with progressive androgen-independent prostate cancer who were treated at the National Cancer Institute from 1990 to 1996 were analyzed. Serum CEA concentrations were measured using a micro-particle enzyme immunoassay. RESULTS: Among these cases of prostatic carcinoma, 69 (48.9%) had abnormally elevated plasma CEA values (greater than the normal upper limit of 2.5 ng/mL) at some time during their treatment on a clinical investigation protocol. No correlation was found between the elevated CEA concentrations and prostate specific antigen (PSA). In comparison, 32.5% of patients with elevated CEAs had disease that had metastasized to soft tissue (adenopathy, etc) versus 22.2% with normal CEA who had soft tissue involvement (p = 0.3 X2). We examined the CEA values with respect to survival time, defined as the interval from the date of the earliest CEA level to the date of death and found no association (p > 0.3). CONCLUSIONS: Based on these observations, it appears that in the context of androgen-independent prostate cancer, CEA can be elevated but is an inviable surrogate marker of disease progression with minimal prognostic value.

Protease activity in a hapten-induced model of ulcerative colitis in rats.

Inflammatory bowel disease (IBD) is a painful and debilitating condition affecting the mucosal lining of the colon and other areas of the gastrointestinal tract. IBD generally falls into two major categories: ulcerative colitis (UC) and Crohn's disease. We have utilized dinitrobenzenesulfonic acid (DNBS) to induce experimental UC in rats. Histopathologic analysis indicates that DNBS induces a condition in animals similar to human UC. Biochemical results revealed 6- to 10-fold elevated levels of serine protease activity in colon tissue from animals with UC as compared with matched controls. We also observed elevated levels of protease activity in tissue samples obtained from human patients with UC. Hence, our results demonstrate that protease activity is increased in rodent and human UC. These proteases may play a significant role in destruction of colonic tissue in IBD. Protease inhibitors that target serine proteases may be useful pharmacological agents to limit tissue destruction in IBD.

Acute rheumatic fever in adults: a resurgence in the Hasidic Jewish community.

OBJECTIVE: To describe a series of adults diagnosed with acute rheumatic fever (ARF). METHODS: Retrospective chart review of 14 patients age > 18 years with suspected ARF between 1990 and 1994 in a private rheumatology practice setting. Four additional patients treated at our medical center were included in the study. RESULTS: Twelve patients met Jones criteria for rheumatic fever and were included in the study. Of these, only 3 had a childhood history of rheumatic fever. All had recent onset of arthritis and a history of antecedent sore throat. Only 4 patients, however, had throat cultures positive for B-hemolytic streptococcus. Nine patients were Hasidic Jews. Four patients had carditis. One patient had erythema marginatum, while chorea and subcutaneous nodules were not seen. Nine patients improved taking nonsteroidal antiinflammatory drugs or acetylsalicylic acid; 3 required steroid treatment to control severe arthritis. CONCLUSION: Our clinical experience suggests that ARF occurs frequently, especially among Hasidic Jewish adults. Due to the disabling nature of the arthritis and the significant incidence (33%) of carditis, strict adherence to penicillin prophylaxis guidelines is indicated.

Panniculitis of pancreatic disease masquerading as systemic lupus erythematosus panniculitis.

We describe a patient with systemic lupus erythematosus (SLE) who presented with severe refractory pannicular lesions diffusely involving the buttocks and lower extremities. Due to the severity of these lesions, a biopsy was performed, which implicated panniculitis associated with pancreatic disease, rather than lupus panniculitis. Serum amylase was normal, but the serum lipase was markedly elevated. An abdominal computerized tomographic scan demonstrated a pancreatic mass, which upon laparotomy was found to be an acinar cell carcinoma. After resection of the mass, her symptoms improved, where they had not responded to prior immunosuppressive therapy. She has subsequently remained well without recurrence of the disease. This case illustrates that an uncharacteristic presentation of panniculitis in a patient with lupus does not necessarily imply lupus panniculitis, and a biopsy is imperative to distinguish other sometimes life threatening etiologies.

Erythema Nodosum versus Erythema Induratum: A Crucial Distinction Enabling Recognition of Occult Tuberculosis.

Erythema induratum, previously uncommon, is appearing more frequently coincident with the recrudescence of tuberculosis. It is a type of panniculitis often confused clinically with erythema nodosum. We report two patients who were both initially believed to have erythema nodosum and a multisystem disorder. However, in each case, the lesions appeared atypical due to suppuration or distribution of the lesions. This led to skin biopsies, which showed the presence of erythema induratum and excluded the panniculitis of erythema nodosum or leukocytoclastic vasculitis. This lesion heightened our suspicion of the presence of tuberculosis, which was subsequently confirmed by culture and/or clinical response.This experience suggests that patients with an atypical presentation of erythema nodosum should have a skin biopsy to exclude a diagnosis of erythema induratum.

Intravenous adenosine: a noninvasive diagnostic test for sick sinus syndrome.

Adenosine has a well established negative chronotropic effect on the sinoatrial node. The most widely utilized test of sinus node function remains the sinus node recovery time (SNRT), which generally requires catheterization. We compared the effect of adenosine (150 mcg/kg IV) on the lengthening of sinus cycle length (ADO:SCL) in 12 control patients (group I) and in 11 patients with clinical sick sinus syndrome (SSS) (group II), eight of whom had undergone prior permanent pacemaker implantation. Using 675 msec as an abnormal result indicating sinus node dysfunction (two standard deviations above the mean value established in controls), ADO:SCL had a sensitivity and specificity of 64% and 100%, which were equal to that observed for the corrected sinus node recovery time (CSNRT) (abnormal value > or = 550 msec). There was a significant difference in the CSNRT between group I (304 +/- 149 msec) and group II (1,199 +/- 916 msec, P = 0.003). There was no significant difference in ADO:SCL between groups I (256 +/- 210 msec) and group II (1,213 +/- 1,719 msec, P = 0.069); however, there was substantial overlap between patients exhibiting an abnormal ADO:SCL and CSNRT. As such, a significant difference in ADO:SCL was evident between group II patients (1,784 +/- 1,950 msec, n = 7) exhibiting an abnormal CSNRT and group I patients, P = 0.014. In conclusion, ADO:SCL has the same sensitivity and specificity for sinus node dysfunction as compared to the CSNRT. Intravenous adenosine may prove to be a useful noninvasive test to assess the need for permanent pacemaker implantation.

Catheter optimization during contrast ventriculography: a prospective randomized trial.

Although newer contrast mediums have improved hemodynamic stability during left ventriculography, the image quality and hence the diagnostic yield of the procedure is largely determined by the choice of catheter and injection technique. In this study 125 patients were prospectively assigned at random to undergo ventriculography using either of two pigtail catheters, one with a straight shaft throughout its length (straight) and one with a 145-degree bend placed 6.5 cm from the distal end (angled). Injectate composition, flow rate, and volume were held constant for all injections, and baseline clinical and catheterization variables were found to be similar in each group. The angled catheter exhibited a statistically superior ease of insertion (p = 0.038) and took less time to position (p = 0.012), saving a mean of 23 seconds of fluoroscopy time per procedure. It was also associated with superior contour edge definition (p = 0.037) and a trend toward more uniform distribution of contrast medium (p = 0.089). Compared with the straight catheter, the angled catheter was less frequently accompanied by artifactual mitral regurgitation (p = 0.038) but was equally likely to provoke ventricular arrhythmias during injection. These observed differences may be explained in part by the tendency for angled catheters to more frequently localize in the central as opposed to the inferoposterior region of the left ventricular cavity (mean distance from center = 0.53 vs 1.10 cm, respectively; p less than 0.001).(ABSTRACT TRUNCATED AT 250 WORDS)

Alternate methods for the determination of atrial capture threshold utilizing the telemetered intracardiac electrogram.

Periodic determination of pacemaker capture threshold is important to ensure appropriate pacemaker function. During dual chamber pacing, it is sometimes difficult to identify evidence of atrial depolarization on surface electrocardiography (ECG), and this can interfere with the ability to ascertain atrial capture. We describe new methods for determining atrial capture threshold using a standard telemetered endocardial atrial electrogram (AEGM). For the first method, the atrial output is decremented until loss of atrial capture is demonstrated by the appearance of native P wave activity on the AEGM. The atrial capture threshold can then be accurately determined as the point at which a stepwise increase in atrial output results in extinction of the native P wave activity. The second method uses the direct visualization of the AEGM recorded between the ring electrode and pacemaker generator during unipolar (lead tip electrode) pacing. This requires the presence of a bipolar lead. Using this method of recording, it is possible to identify a signal after the atrial stimulus artifact during atrial capture, which disappears with loss of capture. This signal is consistent with a paced "evoked atrial potential" and allows verification of atrial capture. After validating the methods in two sets of test patients with clearly identifiable atrial depolarization on surface ECG, one method was successfully applied to a patient in whom atrial depolarization could not be reliably ascertained on surface ECG. These methods promise to be useful in selected patients in whom confirmation of atrial capture would otherwise be difficult.

Variation in P wave amplitude immediately after pacemaker implantation: possible mechanism and implications for early programming.

The P wave amplitude (PWA) plays an important role in determining atrial sensing capabilities. To assess early PWA change, we compared the unipolar PWA in 43 patients at the time of atrial lead placement, measured by a pacing systems analyzer, to the unipolar PWA recorded at the end of pacemaker surgery, from telemetered atrial endocardial electrograms. Individual PWA varied from a decrease of 5.2 mV to an increase of 2 mV (-63% to 267%). In 33 patients with active fixation leads, the implant PWA was 1.96 +/- 0.99 mV versus 2.4 +/- 1.4 mV after surgery. In 11 patients with passive fixation leads, the implant PWA was 2.8 +/- 1.9 mV versus 1.9 +/- 0.8 mV after surgery. The PWA change, measured as the difference between the postsurgical and implant PWA was 0.43 +/- 0.8 mV in active versus -0.86 +/- 1.6 mV in the passive fixation lead groups (P less than 0.05). Considerable change in individual P wave amplitude can therefore occur very early after pacemaker implantation. The direction differs significantly between active (predominantly positive) and passive fixation groups (predominantly negative). These data suggest that an adequate margin of safety is important when initially programming atrial sensitivity, particularly when using passive fixation leads.

Increased exercise capacity after digoxin administration in patients with heart failure.

Failure to objectively assess the effect of digitalis on exercise capacity has resulted in controversy regarding its use in patients with chronic congestive heart failure. To clarify this situation, maximal treadmill testing with respiratory gas exchange analysis was performed on 11 patients (mean age 57 +/- 9 years) with chronic congestive heart failure with and without digoxin therapy. Ten of the 11 had a consistent third sound gallop, and the mean ejection fraction of the group was 24 +/- 10%. Rest heart rate was significantly higher (91 +/- 16 versus 102 +/- 16 beats/min; p less than 0.05) and rest systolic blood pressure was significantly reduced in the absence of digoxin (130 +/- 23 versus 121 +/- 15 mm Hg; p less than 0.05). No differences in heart rate or blood pressure were observed during exercise. Significant increases in ventilatory oxygen uptake were observed with digoxin submaximally (3.0 mph, 0% grade), at the gas exchange anaerobic threshold and at maximal exercise (mean increase of 2.6 ml/kg per min; p less than 0.02). An improvement in the estimated ratio of ventilatory dead space to tidal volume (VD/VT), an index of physiologic efficiency, occurred throughout exercise during digoxin therapy, and there was a significant negative correlation between the change in maximal oxygen uptake and change in maximal estimated VD/VT (r = -0.63; p less than 0.05). Thus, digoxin therapy is associated with a significant improvement in exercise capacity in patients with chronic heart failure, most likely due to an improved matching of ventilation to perfusion.